Showing results (6561-6570 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 14, 2007
Mucosal vaccine vectors: replication-competent versus replication-deficient poxvirusesLukena U Karkhanis, Ted M RossCurrent Pharmaceutical Design|July 14, 2007
Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfateIsrael Vlodavsky, Neta Ilan, Annamaria Naggi, et al.Current Pharmaceutical Design|July 14, 2007
Developing antiangiogenic peptide drugs for angiogenesis-related diseasesK N Sulochana, R GeCurrent Pharmaceutical Design|July 14, 2007
Regulation of angiogenesis and angiogenic factors by cardiovascular medicationsShin-ichiro Miura, Keijiro SakuCurrent Pharmaceutical Design|July 14, 2007
Targeting vascular cell migration as a strategy for blocking angiogenesis: the central role of focal adhesion protein tyrosine kinase familyA Angelucci, M BolognaCurrent Pharmaceutical Design|July 14, 2007
Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targetsC V Iannucci, D Capoccia, M Calabria, et al.Current Pharmaceutical Design|July 14, 2007
Homo obesus: a metabotrophin-deficient species. Pharmacology and nutrition insightG N Chaldakov, M Fiore, A B Tonchev, et al.Current Pharmaceutical Design|July 14, 2007
Epicardial adipose tissue as new cardio-metabolic risk marker and potential therapeutic target in the metabolic syndromeGianluca Iacobellis, Arya M SharmaCurrent Pharmaceutical Design|July 14, 2007
Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndromeGiuseppe BarbaroPageof 1,008